Suchergebnisse - (Person:"Liu, Binliang")

PubPharm (8)

1

Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients : A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Liu, B. | Xie, N. | Tian, C. | +16

2

The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer : Novel prognostic indexes based on ctDNA

enthalten in: Breast (Edinburgh, Scotland) | 2022

von Liu, B. | Hu, Z. | Ran, J. | +4

3

Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2020

von Guan, X. | Liu, B. | Niu, Y. | +9

4

Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer

enthalten in: NPJ breast cancer | 2020

von Yi, Z. | Rong, G. | Guan, Y. | +17

5

The relationship between statins and breast cancer prognosis varies by statin type and exposure time : a meta-analysis

enthalten in: Breast cancer research and treatment | 2017

von Liu, B. | Yi, Z. | Guan, X. | +2

6

The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis

enthalten in: Breast cancer research and treatment | 2017

von Liu, B. | Yi, Z. | Guan, X. | +2

7

The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis

enthalten in: Breast cancer research and treatment | 2017

von Liu, B. | Yi, Z. | Guan, X. | +2

8

The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis

enthalten in: Breast cancer research and treatment | 2017

von Liu, B. | Yi, Z. | Guan, X. | +2

1
[1]